Drug Topics
OCTOBER 14, 2024
Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.
PharmaVoice
OCTOBER 14, 2024
Long-time executives with a strong track record of advancing drug R&D, business savvy strategies and leadership in various sectors of pharma.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 14, 2024
Research presented at ACCP 2024 found that addiction medicine consult services could help increase medication for opioid use disorder initiation.
PharmaVoice
OCTOBER 14, 2024
Digital therapeutics have languished in the background of traditional medicines for years, but a recent reimbursement push may have gotten the ball rolling.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 14, 2024
As health care systems and the current syndemic continue to evolve, pharmacies are poised to play a crucial role in improving public health.
Pharmacy Times
OCTOBER 14, 2024
Employers can support technicians by investing in certification opportunities.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 14, 2024
It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age. An observational study published Monday in JAMA Network Open found that children and adolescents were one-and-a-half times more likely to be diagnosed with the metabolic disorder in the months after having Covid-19 compared to similar kids who weathered other respiratory infections.
Drug Topics
OCTOBER 14, 2024
Researchers addressed the prevalence of RSV and its associations with immunization, infection, and hospitalization amongst older adults.
STAT
OCTOBER 14, 2024
When the U.S. health care system pivoted to meet Covid-19 in 2020, routine health visits and screenings where many cancer cases would have been caught didn’t happen. It wasn’t ideal, but many health experts thought that as the country opened back up, screenings would help “catch up” to these missed cases. A new paper published Monday in JAMA Network Open suggests that didn’t happen as quickly as experts had hoped.
Drug Topics
OCTOBER 14, 2024
The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
OCTOBER 14, 2024
Eli Lilly may invest $364m in the UK and work with the government to tackle serious public health challenges including obesity.
Pharmacy Times
OCTOBER 14, 2024
The lawsuit alleges that the action was taken without the required notice and disputes the agency’s warning of “localized supply disruption,” while calling for more transparency.
STAT
OCTOBER 14, 2024
Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. But there’s one field that has seen an even more significant amount of activity: autoimmune diseases. Companies that are developing new medicines for autoimmune conditions, as well as other immune system disorders, have brought in more money and closed more deals so far this year than most other areas, including the cardiometabolic field, data from investment bank Oppenh
Pharmacy Times
OCTOBER 14, 2024
Criticism and inquiry are coming from all directions. Will investors earn more by holding on to the past or transitioning toward the future?
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 14, 2024
LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth $2.6 billion. As part of the deal, which is expected to close in the fourth quarter, Lundbeck is paying $60 per share in cash for Longboard, a 54% premium on Friday’s closing price of $38.90.
Pharmacy Times
OCTOBER 14, 2024
The authors of these peer -reviewed papers collectively emphasize the evolving landscape of oncology treatment.
IDStewardship
OCTOBER 14, 2024
In this article an infectious diseases pharmacist discusses something cool and something lame with 5 antibiotics. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the August 2024 IDstewardship Newsletter 1. Ciprofloxacin Something cool: It can be given orally to treat a variety of different Pseudomonas aeruginosa infections – yay for avoiding intravenous catheters!
Pharmacy Times
OCTOBER 14, 2024
Artificial Intelligence (AI) is transforming drug development by automating routine tasks, enhancing clinical trials, and expediting drug discovery, ultimately leading to more personalized treatments.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
IDStewardship
OCTOBER 14, 2024
In this article an infectious diseases pharmacist with 20+ years of experience in the profession discusses 5 quick things to know about drug shortages. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the July 2024 IDstewardship Newsletter 1. Not all drug “shortages” are created equal When someone says there is a “shortage” of drug, that can mean a lot of different things.
Pharmacy Times
OCTOBER 14, 2024
In this interview for World Standards Week, Nakia Eldridge, PharmD, MPH, of US Pharmacopeia (USP), discusses USP's key achievements in 2024, while outlining the organization's 2025 goals.
IDStewardship
OCTOBER 14, 2024
In this article a pharmacist with experience in writing and publishing provides 5 quick tips for pharmacy residents preparing manuscripts Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the June 2024 IDstewardship Newsletter Tip 1: Start by picking an article type and journal The article type (e.g., brief report, concise communication) will provide structure guidance (number of words, figures/tables, references allowed).
Pharmacy Times
OCTOBER 14, 2024
Ilianette Miranda, RPh discusses her career-long efforts to integrate pharmacists into the health care system in Puerto Rico.
IDStewardship
OCTOBER 14, 2024
In this article an infectious diseases pharmacist discusses 5 examples where challenging antibiotic workflows can be an issue. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the October 2024 IDstewardship Newsletter 1. The time it takes to make a dose of Amphotericin B Not giving Ambisome today but the order is active as if one is due?
Pharmacy Times
OCTOBER 14, 2024
Behind The Script is a photo submission campaign designed to feature real pharmacists with candid, HIPPA-compliant photos to celebrate American Pharmacist Month.
IDStewardship
OCTOBER 14, 2024
In this article an infectious diseases pharmacist discusses 5 neat things from the world of antimicrobials – let’s get nerdy! Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the September 2024 IDstewardship Newsletter 1. Echinocandins are associated with a paradoxical effect Giving more drug leads to less fungal killing?
Pharmacy Times
OCTOBER 14, 2024
Offering pharmacy professionals insights into the benefits, importance and challenges associated with switching patients to long-acting injectables to treat schizophrenia.
STAT
OCTOBER 14, 2024
The Broad Institute of MIT and Harvard , one of the most prominent biotech research centers in the world, has laid off 87 employees, a spokesperson confirmed. The layoffs came as a lucrative partnership with Microsoft was expected to conclude at the end of the year. In an email to staff Thursday, Todd Golub, the Broad’s director, attributed the cuts to the “rapid pace of technological and scientific change [which] requires us to retool to stay ahead” in the institute&#
Pharmacy Times
OCTOBER 14, 2024
Pharmacists and the pharmacies they support are in a strong position to increase vaccination rates and address any questions related to vaccine hesitancy.
STAT
OCTOBER 14, 2024
When children’s hospitals around the country were subject to threats and harassment in 2022 over misconceptions about gender-affirming care services, many of them responded by stripping information about the care from their websites. Two years later, new research shows that few adult and children’s hospital websites share information about LGBTQ+ services and policies.
Fierce Pharma
OCTOBER 14, 2024
Four days after a compounding industry group filed a lawsuit against the FDA | Four days after a compounding industry group filed a lawsuit against the FDA for removing Eli Lilly’s tirzepatide products from its shortage list, the U.S. regulator is taking a second look at its decision.
STAT
OCTOBER 14, 2024
A transplant to Boston from Brazil, my patient worked as a hairdresser but had developed painful rashes on her hands that peeled and cracked, making it impossible to do her job. I diagnosed her with an allergy to para-phenylenediamine, an ingredient in certain styling products she used at the salon. Her skin recovered as she avoided this chemical. A careful medical evaluation had healed her hands and allowed her to maintain her livelihood, her self-sufficiency, and the social connections with co
pharmaphorum
OCTOBER 14, 2024
GSK's six-monthly IL-5 inhibitor depemokimab clears two phase 3 trials in chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication
STAT
OCTOBER 14, 2024
Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, reported on Monday that its experimental drug helped patients with a chronic skin condition in an initial and closely watched clinical trial. In the Phase 1/2 study, dubbed Spotlight, 14 of 15 patients given an injection of the drug, briquilimab, showed improvements in symptoms of chronic inducible urticaria, a disease defined by red, itchy welts.
Expert insights. Personalized for you.
581 
Let's personalize your content